共 90 条
[1]
Forman D(2012)Global burden of human papillomavirus and related diseases Vaccine 30 F12-F23
[2]
de Martel C(2014)Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet 383 524-532
[3]
Lacey CJ(2012)Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway Br J Cancer 106 1571-71
[4]
Soerjomataram I(2015)Kostnader ved masseundersøkelsen mot livmorhalskreft Sykeplein Forskning 10 62-147
[5]
Lortet-Tieulent J(2014)Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys PLoS ONE 9 e89974-2201
[6]
Bruni L(2012)Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark BMC Public Health 12 1082-426
[7]
Vignat J(2017)The economic burden of human papillomavirus-related precancers and cancers in Sweden PLoS One 12 142-128
[8]
Ferlay J(2018)Activity-based costing and time-driven activity-based costing for assessing the costs of Cancer prevention, diagnosis, and treatment: a systematic review of the literature Value Health Reg Issues 17 djv086-316
[9]
Bray F(2015)US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines J Natl Cancer Inst 107 2197-402
[10]
Plummer M(1996)Cost of breast cancer treatment: a 4-year longitudinal study Arch Intern Med 156 417-undefined